Dow Jones Newswires, "FDA Warns Pfizer About Celebrex, Bextra Ads"
The Food and Drug Administration warned Pfizer Inc. that it left out risk information and made unsubstantiated effectiveness claims in advertisements for its painkillers Celebrex and Bextra. According to a copy of a fax sent to Pfizer Vice President of U.S. Regulatory Affairs Robert Clark and posted on the agency's Web site, the agency is asking Pfizer to "immediately cease the dissemination" of the promotional materials which the FDA cited.